# A Study of ZW251 in Participants With Advanced Solid Tumors

> **NCT07164313** · PHASE1 · RECRUITING · sponsor: **Zymeworks BC Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Squamous Cell Non-Small Cell Lung Cancer
- Germ Cell Tumor

## Interventions

- **DRUG:** ZW251

## Key facts

- **NCT ID:** NCT07164313
- **Lead sponsor:** Zymeworks BC Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-21
- **Primary completion:** 2027-09
- **Final completion:** 2028-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07164313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07164313, "A Study of ZW251 in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT07164313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*